COVID antibody treatments show promise for preventing severe disease

Nature. 2021 Mar;591(7851):513-514. doi: 10.1038/d41586-021-00650-7.
No abstract available

Keywords: Immunology; SARS-CoV-2; Virology.

Publication types

  • News

MeSH terms

  • Antibodies, Monoclonal / immunology
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized / immunology
  • Antibodies, Monoclonal, Humanized / therapeutic use
  • Antiviral Agents / immunology
  • Antiviral Agents / therapeutic use*
  • COVID-19 / mortality*
  • COVID-19 / pathology
  • COVID-19 / physiopathology
  • COVID-19 Drug Treatment*
  • Hospitalization / statistics & numerical data
  • Humans
  • Randomized Controlled Trials as Topic
  • Spike Glycoprotein, Coronavirus / chemistry
  • Spike Glycoprotein, Coronavirus / genetics
  • Spike Glycoprotein, Coronavirus / immunology
  • Spike Glycoprotein, Coronavirus / metabolism
  • Time Factors
  • United States / epidemiology

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antiviral Agents
  • Spike Glycoprotein, Coronavirus
  • spike protein, SARS-CoV-2
  • sotrovimab
  • bamlanivimab
  • etesevimab